CASI Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. CASI Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 21% to $33,879,000. The net income raised on -$26,938,000 and profit margin reached -80%. Total operating expenses were $45,132,000.
Profit Margin
| 2014 | 23.72K | -26.20M | -110432.45% |
|---|---|---|---|
| 2015 | 47.71K | -7.20M | -15104.01% |
| 2016 | 0 | -9.45M | |
| 2017 | 0 | -10.77M | |
| 2018 | 0 | -27.47M | |
| 2019 | 4.13M | -51.40M | -1244.44% |
| 2020 | 15.14M | -62.56M | -413.23% |
| 2021 | 30.16M | -37.77M | -125.21% |
| 2022 | 43.10M | -39.41M | -91.43% |
| 2023 | 33.87M | -26.93M | -79.51% |
CASI Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 33.87M | 43.10M | 30.16M | 15.14M | 4.13M | 0 | 0 | 0 | 47.71K | 23.72K |
Cost of revenue | 13.82M | 15.82M | 12.55M | 9.50M | 3.93M | 1.67M | 117.77K | 66.45K | 6.27K | 7.46K |
Gross profit | 20.05M | 27.28M | 17.61M | 5.63M | 196K | -1.67M | -117.77K | -66.45K | 41.43K | 16.26K |
Operating exp. | ||||||||||
Research and development | 9.86M | 15.99M | 14.42M | 11.47M | 9.74M | 8.50M | 7.59M | 4.64M | 4.07M | 2.76M |
Selling and marketing | 16.45M | 14.32M | 14.70M | 7.81M | 3.10M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 45.13M | 53.77M | 52.89M | 38.94M | 40.18M | 26.50M | 10.75M | 9.42M | 7.19M | 6.52M |
Operating income | -25.08M | -26.49M | -35.28M | -33.31M | -39.99M | -26.50M | -10.75M | 9.42M | 7.15M | 26.18M |
Other income (expenses), net | -1.21M | -10.94M | -560K | -14.19M | -5.37M | -1.00M | -18.88K | -6.78K | -54.02K | -19.69M |
Income before tax | -26.29M | -37.43M | -35.84M | -47.51M | -45.36M | -27.47M | -10.77M | -9.45M | -7.20M | -26.20M |
Income tax expense | -81K | 1.98M | 1.93M | 15.05M | 6.04M | -958.91K | 14.97K | 33.80K | 82.45K | 28.06K |
Net income | -26.93M | -39.41M | -37.77M | -62.56M | -51.40M | -27.47M | -10.77M | -9.45M | -7.20M | -26.20M |
Earnings per share | ||||||||||
Basic EPS | -2.02 | -2.89 | -2.78 | -5.66 | -5.36 | -3.24 | -1.75 | -1.69 | -2.22 | -9.16 |
Diluted EPS | -2.02 | -2.89 | -2.78 | -5.66 | -5.36 | -3.24 | -1.75 | -1.69 | -2.22 | -9.16 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |